Skip to main content Help with accessibility Skip to main navigation

OSPEMIFENE tablets (Senshio®) for vulvar and vaginal atrophy in post-menopausal women

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 06 - Oct - 2023
Body System:
Grey
OSPEMIFENE tablets (Senshio®) for vulvar and vaginal atrophy in post-menopausal women

The Cheshire and Merseyside Area Prescribing Group does not currently recommend the prescribing of OSPEMIFENE tablets (Senshio®) for vulvar and vaginal atrophy in post-menopausal women.